SARS-CoV-2 Neutralizing Antibody
This rabbit monoclonal antibody was raised against the RBD domain of the SARS-CoV-2 S1 protein (Arg319 to Phe541, sequence below). The antibody was validated through binding assays (ELISA) and neutralization assays for its ability to neutralize SARS-CoV-2 pseudoviruses such as Ha-CoV-2 and Ha-CoV-2 variants ( e.g. delta and omicron). The antibody was expressed in mammalian cells and purified as a recombinant protein.
More in Cell Lines, Antibodies & Controls
Other Virongy products in the same category.
ExoMaxed™
Exo-HEK293T enhances the production of exosomes and microvesicles, providing customers with consistent production of…
HIV Rev-dependent Reporter Cells
The HIV Rev-dependent reporter cells represent a major advancement in the development of HIV indicator cells ( Wu et…
R8.71 HIV-1 RCL Positive Control Virus
HIV-1 R8.71 replication-competent lentivirus (RCL) positive control virus, supplied at a titre greater than 5 x 10⁵…
